Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

Abnormal cell proliferation is a major hallmark of cancer. Several proteins are involved in the cell cycle, and most of these ...

A novel approach to cancer vaccine design has replaced the vulnerable O-glycosidic linkage in sialyl-Tn antigens with a ...

Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...

Details and references regarding individual diseases are provided in the Supplementary Appendix. CIDP denotes chronic inflammatory demyelinating polyneuropathy, Covid-19 coronavirus disease 2019, and ...

Amyotrophic lateral sclerosis may involve an autoimmune component — a finding that could reshape treatment strategies and ...

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

KDM5 inhibition/disruption selectively induces R-loop-mediated DNA damage and innate immune activation in breast cancer cells, while sparing normal cells, unveiling a tumor-specific therapeutic ...

For the first time, a man with type 1 diabetes (T1D) is making his own insulin after undergoing islet cell transplantation and without any use of immunosuppression, researchers reported. This was made ...